American Healthcare REIT (AHR) EBIT (2016 - 2026)

American Healthcare REIT (AHR) has reported EBIT for 11 consecutive years, with -$482.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBIT fell 26.99% year-over-year to -$482.4 million; the trailing twelve-month figure through Jun 2026 stood at -$1.8 billion (down 17.0% YoY), and the FY2025 full-year result was -$1.6 billion, down 6.92% from the prior year.
• EBIT retreated to -$482.4 million in Q2 2026 per AHR's latest filing, from -$473.3 million in the prior quarter.
• Across five years, EBIT topped out at -$210.8 million in Q4 2023 and bottomed at -$482.4 million in Q2 2026.
• Historically, EBIT has averaged -$384.7 million across 5 years, with a median of -$387.3 million in 2024.
• The sharpest annual moves came in 2023 and 2024: EBIT surged 46.92% in 2023, then tumbled 85.62% in 2024.
• Over 5 years, EBIT stood at -$397.1 million in 2022, then jumped by 46.92% to -$210.8 million in 2023, then sank by 85.62% to -$391.2 million in 2024, then slipped by 13.45% to -$443.9 million in 2025, then retreated by 8.68% to -$482.4 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered -$482.4 million, -$473.3 million, and -$443.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.